| Tag | Content |
|---|
EnhancerAtlas ID | HS060-05422 |
Organism | Homo sapiens |
Tissue/cell | GM12891 |
Coordinate | chr11:33888470-33890890 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU2F2 | MA0507.1 | chr11:33888763-33888776 | TTCATTTGCATAT | + | 7.82 | | Pou2f3 | MA0627.1 | chr11:33888762-33888778 | TTTCATTTGCATATAG | - | 6.82 | | TCF7L2 | MA0523.1 | chr11:33889956-33889970 | GGACTTCAAAGGAA | + | 6.11 | | ZNF263 | MA0528.1 | chr11:33890511-33890532 | GAAGGAGAGGGAAGAAGGGAG | + | 6.84 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09380 | chr11:33878912-33893880 | CD14 | | SE_12967 | chr11:33888828-33890954 | CD34_Primary_RO01480 | | SE_13375 | chr11:33888144-33897840 | CD34_Primary_RO01536 | | SE_14120 | chr11:33888879-33893611 | CD34_Primary_RO01549 | | SE_40313 | chr11:33888455-33889564 | K562 | | SE_40313 | chr11:33889620-33893128 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 33889104 | 33889440 | | chr11 | 33888600 | 33889000 |
|
Enhancer Sequence | CCCTAGCTTT TTCATGTGTA TCAACTCAGA GTTGCATCTC TTCTCTTTCC ACAGCCCATG 60
GTCTTACTCT GGGCTTTCAA AACCACTCAT GGAACCTGGA CGCACATTGG ATGTCCCGAT 120
GTTGATGCTG CCAAAGGACT GTGAAAGAAG AGAATTTGCC CTTAGCTGGT GCAAAACTGC 180
CTGGAATTCA AATGAACTGC TCTTGTTACT CACAGGGGAG GCAGTGGGGG CCACCAGTAG 240
CACAGCAAGG GAATCTGTGT TCATGAATTC TGGCTGGCTT TCTGTCCAAA TGTTTCATTT 300
GCATATAGCT AGGCAAGTCT CCATCTGTAA TTTGGAGATG CTGATTGTAA TGACCCAAGC 360
TGGATTTGAG GAAGTACACA ATGAAGCATC TAGTAGGATA CTGGACAACA GGAGGAATGT 420
AAAGTAAAAG AGTTACGGTG ATGGCCTGAG ATGAGATGGA GAAGTAAAGT ATAAGATATT 480
GGCTCTGTCT TTCTATACTT AATTAATGAT AATATCACAT TATACTTAGT GGACAATCCA 540
AGACAATGAC TGAATTAGAT TGATTCACCC TCAAATTAAT ATTTTATATT CTCCCAGACC 600
CTTATCTTGA ATATTACACC TGAGTATCAT TTAAGCCTGG ATTTCTGGGA CAATCATAAC 660
AATTTCTAAG GGCATGGGGA GAATGTGCTG CAGCAATTTC TCAACTGGCT TGTCCCTCTT 720
TGATCAGAAT CTGTCTTCGT TGGGCAAATA GTGAAGTGAA GGAAGGAGCT GGTGAGCCTC 780
CAGCAGTAGA TATCTGTTGT ATTAGGAAGT TAGGATGTTT CAGTTTCTAA CCTCAGTGAA 840
AAAGCACAAA CTTTGAAAGA AGCAAACTTC CTTCAGGGAA ATGAAACCTT CAGATTAATC 900
TTCTATTGAA AGGATTAGTG ACTAAATTCT GCTGATCAAA AAGGCATGAG GCACCAATTC 960
ATCCAATTCA CTCCCTTATT GTGTTACTAT GATCTTGCCC AGTCTCTGAA ACTCAGAGCT 1020
CAGTTTTAAG TTTATTTTAA AAAAGTGATC AAACCACCCT TTAAACCCAT TGTTTGCATA 1080
AACATACTTT TAAAAAGGAA TGTTATTTTT CTCCTGAGAA TTTGTTGAAG GAAGTGGGGG 1140
TTTTTGTTAT AACAAACCTA GCTCATTACA GAACTGGTGT CTTAACCTTC AAGACTGAAT 1200
AGTGATGTTT ATATTCTCAT TGGATGGTGG TACTTCCTGT GTTTTATGAG AATATGTTGA 1260
GCTTTTATGC TGGTAACTGA GGGTAAAACC CAGGTAAATA AACACCATAG AAAGCCGAAA 1320
TTGAAGGGTG TATGTGTGTG TGTGCGGTAT TTCAAGCAGG AAAGCACAAT TCTTTTAAAG 1380
CAGGAAAAGA AAAAACAAAA CAAATGTCTC TTAAAAGCAC AAATGGACAA GTCATTAACC 1440
AGCTCCTTTG GTCTTGTGTA ACAAATCCCT TCAAAGGATT AGAGGGGGAC TTCAAAGGAA 1500
TAAAAATTCT CAAAACCAGA CAGCTAATGA CTCTTAAAAG GGCATTTGCG TTGACAGGAA 1560
AATGATATCT TAAACACCCC TTACTCCCCA TGTTAACGCT GAAGAATGGG TGAGGGATAG 1620
AAAAACATTC CAAACCAGTA CGCGGCTCAG AAAACAGATG CGGCCAATGC TCATTAGAGC 1680
TCTGGTTCCC TGACCCCAAA CCCTTTTAAG ACTCTGCTAA AAACTACGAG ACTCTACTCC 1740
CCAGAATAAT TCACCTATAC ACAAAATGGT GCATTAACTT TCGAGGTTCA CATGTCCCCA 1800
TCGGTGGACC CCGAGGAGGG GTACACCTAC TCAGATTTAC TCCGGATTTC GCTGCTCTAG 1860
AAATCCCTGG AGGCCCAGAG CCAGCTCCGA GGTGGACGGT CGGACCCCTC ACCCGCCCGT 1920
TATCCGCAAG GCTGGCAGCG GCTCCACCTG CGGACCGGGA AGGCGGCCGT TGGGGACCCC 1980
GGAGGCCGCC ACTTGGAATG TTCCCCTTTC CAAGACCAAA TGGACAAAGA GAAAGGACCG 2040
AGAAGGAGAG GGAAGAAGGG AGCAGAGTCA AGCCCAGAAC GCTCTCCGGA CTGCACCTGC 2100
GCGCCTCCAG GCTCTCCTCG TGCCTGCTCC CGTGCAAACT TTCTGGCCCG TGGTGGCTTT 2160
GGGGAGCGTC CCAGTAGCCT GGAGTGGCCC GCAGAGGCGC CGGGCCGACC CCTGTCCCTG 2220
CCGCCCGCCG CCCAGTCCCT CTCCCAGAGC CCCCGGAATC ACCCGGGAGG AAGGAGGAGC 2280
CCAGCGCTCG GCACAGGGGG CCAAGGGCAC GCCGCGAGCG CGCACCTGGA GCCCCCTCGC 2340
GGGCCGCCCG GGTCCCCCCG ACGCTCCGGG ACGCGAGGCC GTGGACACCG GGGGTGGCAG 2400
GGGCAGGGGG GCCGCACTTA 2420
|
